title: Hepatitis C treatment in dialysis patients: is a new dawn approaching?
authors.affiliation: Boston University Medical Center, Boston, Massachusetts. Electronic address: craig.gordon@bmc.org.
authors.forename: Craig E
authors.initials: CE
authors.lastname: Gordon
authors.affiliation: Boston University Medical Center, Boston, Massachusetts.
authors.forename: Jean
authors.initials: J
authors.lastname: Francis
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D006435:Renal Dialysis; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin